Results 61 to 70 of about 7,222 (160)
, 2022 Coronavirus disease 2019 (COVID-19) continues to pose a threat to public health with the potential for the emergence of new variants. Vaccines are the milestones to control and slow down the damage of the pandemic.
Saricaoglu, Tuğba +22 more
core +1 more source
Humoral Immune Response to Breakthrough Infection With SARS‐CoV‐2 Delta and Omicron Variants
iLABMED, Volume 3, Issue 3, Page 266-274, September 2025.Patients with breakthrough infections of the Omicron variant exhibited significantly higher levels of neutralizing antibodies and IgG than those infected with the Delta variant. By contrast, Delta‐infected patients showed higher levels of IgM and IgA than Omicron‐infected patients.
Xihong Zhang +12 more
wiley +1 more source
Human T Cell Responses to Flavivirus Vaccines
European Journal of Immunology, Volume 55, Issue 8, August 2025.This review summarises current knowledge of T cell responses induced by flavivirus vaccines being licensed or under development. Existing vaccines against flaviviruses have been developed and analysed primarily in the context of antibody responses, while the role of T cells in contributing to immunity against flaviviruses is less studied.
David Wullimann, Hans‐Gustaf Ljunggren
wiley +1 more source
Intradermal ChAdOx1 Vaccine Following Two CoronaVac Shots: A Case Report
, 2021 Inactivated SARS-CoV-2 vaccines are used in many countries with uncertain immunogenicity. Intradermal ChAdOx1 has been proposed as a resource-efficient heterologous third booster shot.
Ekachai Singhatiraj +7 more
core +1 more source
Journal of Medical Virology, Volume 97, Issue 8, August 2025.ABSTRACT Since the slavery period in Brazil, the Quilombola population has faced problems related to social vulnerability and poor health. The coronavirus disease (COVID)‐19 pandemic has made this social inequality more evident, and the postpandemic scenario has proved even more challenging with the difficult access to basic living conditions ...
Patrícia Teixeira Costa +4 more
wiley +1 more source
, 2023 Previous reports have shown that heterologous boosting with the AD5-vectored COVID-19 vaccine Convidecia based on a primary series of two doses of inactivated vaccine induces increasing immune responses.
Peng Wan +9 more
core +1 more source
Journal of Medical Virology, Volume 97, Issue 6, June 2025.ABSTRACT This nationwide population‐based ecological study investigated changes in the incidence of Bell's palsy (BP) in South Korea during the COVID‐19 pandemic. Patients diagnosed with BP between January 2017 and December 2022 were analyzed. Considering the unique progression of the COVID‐19 pandemic and corresponding public health responses in South
Seungyeon Lee +3 more
wiley +1 more source
, 2023 Introduction: Data regarding inactivated vaccines for SARS-CoV-2 in patients undergoing maintenance hemodialysis (MHD) are limited. We aimed to investigate humoral responses induced by CoronaVac compared to BNT162b2 in this population.
TUĞCU, MURAT +1 more
core +1 more source
Revolution of AAV in Drug Discovery: From Delivery System to Clinical Application
Journal of Medical Virology, Volume 97, Issue 6, June 2025.ABSTRACT Adeno‐associated virus (AAV) is a non‐enveloped DNA virus infecting a wide variety of species, tissues, and cell types, which is recognized as a safe and effective method for delivering therapeutic transgenes. AAV vector is the most popular viral gene delivery system in clinical delivery systems with unique and multiple advantages, such as ...
Ling Yin +6 more
wiley +1 more source
Immunogenicity of the CoronaVac vaccine in children: a real-world study
Frontiers in ImmunologyBackgroundDespite its proven effectiveness and safety, there are limited real-world data on CoronaVac’s immunogenicity in children, especially in lower-income countries, particularly for SARS-CoV-2 variants. We present a real-world study evaluating CoronaVac’s immunogenicity in Colombian children stratified by previous exposure to this virus.Methods89 ...
Wbeimar Aguilar-Jimenez +14 more
openaire +3 more sources